Assessing Response to First-Line Therapy in Advanced Endometrial Cancer: Clinical Factors

News
Video

Insight into the typical response to first-line chemotherapy in advanced endometrial cancer and the clinical factors that influence treatment outcomes, with a focus on improving therapies for this high-risk cohort.

Related Videos
Corey Cutler, MD, MPH, and Hana Safah, MD, experts on GvHD
Corey Cutler, MD, MPH, and Hana Safah, MD, experts on GvHD
Joshua K. Sabari, MD, an expert on lung cancer, presenting slides
Mitchell S. Cairo, MD, and Sergio Giralt, MD, experts on veno-occlusive disease